Psoriasis is a chronic inflammatory skin disorder affecting approximately 60 million people worldwide. The condition presents with rapid hyperproliferation and dysregulated differentiation of epidermal keratinocytes, manifesting clinically as salmon pink plaques with overlying silvery-white scale.

Christi Shaw, former CEO, Kite Pharma, shares her thoughts on improving access to cell therapies and her motivations for working in oncology

Exploring the current state of the US pharmaceutical market, this article investigates the balance between innovation and access to care in the country.

Roche’s Davidek Herron offers his thoughts on the state of diversity, equity and inclusion in the pharma industry.

Despite continued advances in personalised medicine, there is still more to be done to encourage policy makers and payers to back these life-changing initiatives.

Sodium valproate, or valproic acid (VPA), is an antiepileptic drug used for the treatment of epilepsy, bipolar disorder, migraine headache, and diabetic-neuropathy related pain. Valproate-induced pancreatitis is an idiosyncratic reaction of the drug, commonly seen in paediatrics…

In 2021, the UK was named the sixth biggest pharmaceutical market, but it’s facing challenges to further growth. Read to find out more.